How to Approach the Most Critical Measurement in TMVR Planning
By Dr. Dee Dee Wang, M.D., FACC, FASE - Director, Center for Structural Heart Disease and Medical Director, 3D Printing at the Henry Ford Innovations Institute
Transcatheter mitral valve replacement (TMVR) is a treatment that requires detailed pre-procedural planning. 3D models derived from CT scans offer the ability to assess patient anatomy and plan for a procedure in a more intuitive, accurate, and consistent way.
In this webinar Dr. Wang from the Henry Ford Institute shares how she approaches the most critical measurement in TMVR planning: the neo-LVOT.
She explains how using CT-derived models for 3D planning provides unprecedented insight into the neo-LVOT and clinical confidence for the interventional teams.
In this webinar, you will learn:
To identify the mechanisms of LVOT obstruction
The importance of 3D modeling to correctly identify the neo-LVOT with different implant types/designs
To estimate patients risk based on neo-LVOT measurements
Materialise medical device software may not be available in all markets because product availability is subject to the regulatory and/ or medical practices in individual markets. In countries where no regulatory registration is obtained of Mimics and/or 3-matic Medical, a research version is available. Please contact your Materialise representative if you have questions about the availability of Materialise medical device software in your area.
Dee Dee Wang,
MD, FACC, FASE, FSCCT
Henry Ford Health System, USA
Dr. Wang is a Level 3 Cocats trained in echocardiography (with 3D TEE), nuclear, and cardiac CTA; and a Level 2 Cocats trained in cardiac MRI and cardiac PET. She specializes in interventional imaging in structural heart interventions including transcatheter mitral valve replacement therapies, tricuspid interventions, mitral e-clip, complex TAVRs/adult-congenital cases, LAA interventions, and ASD/PFO closures. Dr. Wang’s research interests are focused on advancing patient safety and procedural outcomes utilizing 3D+4D imaging and 3D printing for high-risk structural heart interventions.